Created with Sketch.
ASA Biopharm's Podcast
35 minutes | 3 days ago
Episode 83: Vaccine Development
Kerry Go and Elaine Hoffman discuss vaccine development.
50 minutes | a month ago
Episode 82: Olga Marchenko and Natallia Katenka
Olga and Natallia discuss their new book Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications.
103 minutes | 2 months ago
Episode 81: Mentor-Mentee Pairs from the BIOP Mentoring Program
This episode features discussions with 3 mentor-mentee pairs from the Biopharmaceutical Section mentoring program. Conversations include Qing Li and Abie Ekangaki (start 1:25), Samson Ghebremariam and Scott Clark (start 44:33), and Carie Kimbrough and Bruce Binkowitz (start 102:29). They discuss the benefits of mentoring and the dynamics of the mentoring relationship.
48 minutes | 3 months ago
Episode 80: 2020 Regulatory-Industry Statistics Workshop
Yabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual.
67 minutes | 4 months ago
Episode 79: Nusrat Rabbee
Nusrat discusses biomarker analysis throughout clinical development and her recent book Biomarker Analysis in Clinical Trials with R.
54 minutes | 5 months ago
Episode 78: Challenges with Pain Assessments
Dottie Brown, Ciprian Crainiceanu, and Jean Recta discuss how pain is quantified in human and animal trials.
54 minutes | 6 months ago
Episode 77: National Institute of Statistical Sciences
Nancy Flournoy, Dan Holder, and Jim Rosenberger discuss the mission and history of the National Institute of Statistical Sciences and how it will adapt for the future.
47 minutes | 8 months ago
Episode 76: COVID-19 and Clinical Trials
Mouna Akacha, Yongming Qu, and Aileen Ward discuss COVID-19 and the operational and statistical effects on clinical trials.
53 minutes | 8 months ago
Episode 75: Meijuan Li
Meijuan Li discusses precision medicine, diagnostic devices, and the importance of parallel development of drugs and diagnostics.
47 minutes | 9 months ago
Episode 74: Glen Colopy and the Pod of Asclepius
Glen discusses his graduate training in data science in the United Kingdom, vital sign monitoring, the challenges of efficient drug supply, and his healthcare technology podcast, the Pod of Asclepius.
45 minutes | 10 months ago
Episode 73: Bruce Binkowitz
Bruce discusses the Japanese regulatory environment, challenges for statistics departments spread across the globe, and his hopes and plans for the Biopharmaceutical Section in 2020.
56 minutes | a year ago
Episode 72: Abie Ekangaki
Abie discusses opportunities for statisticians in the CRO industry, and we chat about the Scholarship and Leadership-in-Practice Committees of the Biopharmaceutical Section.
59 minutes | a year ago
Episode 71: P-values in Medical Product Development
Lisa LaVange, J. Jack Lee, and Steve Ruberg about the ASA Statement on p-values, and their recent paper entitled “Inference and Decision Making for 21st-Century Drug Development and Approval” which was featured in the American Statistician in early 2019.
46 minutes | a year ago
Episode 70: 2020 International Conference on Health Policy Statistics
Kate Crespi and Ofer Harel discuss the 2020 International Conference on Health Policy Statistics, and describe current topics of interest in health policy including gun violence and opioids.
51 minutes | a year ago
Episode 69: Non-proportional Hazards
Keaven Anderson, Pralay Mukhopadhyay, and Satrajit Roychoudhury discuss non-proportional hazards in a regulatory setting.
44 minutes | a year ago
Episode 68: 2019 Regulatory-Industry Statistics Workshop
Judy Li and Renee Rees discuss what's new and exciting at the 2019 Regulatory-Industry Statistics Workshop.
51 minutes | a year ago
Episode 67: Task Force on Sexual Harassment and Assault
Donna LaLonde, Kristian Lum, and Leslie McClure discuss the ASA Task Force on Sexual Harassment and Assault.
41 minutes | a year ago
Episode 66: Quality Tolerance Limits
Rakhi Kilaru and Olgica Klindworth discuss risk-based monitoring and quality tolerance limits.
46 minutes | 2 years ago
Episode 65: Immuno-oncology
Inna Perevozskaya and Bo Huang discuss the changing landscape in oncology clinical development.
53 minutes | 2 years ago
Episode 64: Biopharmaceutical Software Scientific Working Group
Alex Dmitrienko and Kyle Wathen talk about the development of software for biopharmaceutical applications, the new working group and LinkedIn group, and talk a little bit about the new YouTube Channel for the Biopharmaceutical Section.
Terms of Service
© Stitcher 2020